Global Sublingual Spray Market Size by Drug Class (Antianginal Agents, Vasodilators), by Distribution Channel (Hospital & Clinics), by Form (Unit Dose Spray) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1332034
  • |
  • Date : October 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Sublingual sprays are to be sprayed under the tongue for faster effect of enabling the drug absorbed directly through the mucosal lining beneath the tongue.

The Global Sublingual Spray Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Ease in administration of the medicine and enhance compliance facility associated with the drug are stimulating the market growth. However, presence of open mouth sore and effects of drinking and eating habits might become barrier to the market growth in the forecast period.

The global sublingual spray market is primarily segmented based on different drug class, form, distribution channel and region. On the basis drug class, market is segmented into antianginal agents and vasodilators, calcium channel blocking agents and group iv antiarrhythmics and vitamin and mineral combination. . On the basis of form, market is segmented into unit dose spray and bidose spray. On the basis of distribution channel, market is segmented into hospital & clinics, retail & online pharmacy and other distribution channel On the basis of regions, market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

On the basis of drug class, the market is split into:
* Antianginal Agents
* Vasodilators
* Calcium Channel Blocking Agents
* Group IV Antiarrhythmics
* Vitamin And Mineral Combination

On the basis of form, the market is split into:
* Unit Dose Spray
* Bidose Spray

On the basis of distribution channel, the market is split into:
* Hospital & Clinics
* Retail & Online Pharmacy
* Other Distribution channel

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Perrigo Company Plc.
* Insys Therapeutics, Ltd.
* Sun Pharmaceutical Ltd.
* Mist Pharmaceuticals
* NovaDel Pharma Inc.
* Generex Biotechnology Corp.
* GW Pharmaceutical Plc.
* Europlaz Technologies
* Piramal Enterprises Ltd.
* Others

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, drug class and distribution channel market size and their forecast from 2018-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions drug class and distribution channel with qualitative and quantitative information and facts

Target Audience:
* Sublingual Spray Manufactures
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research follows by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data products, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data products.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Sublingual Spray Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Sublingual Spray Market - Porter\'s Five Forces Analysis
4.4. Global Sublingual Spray Market - PESTEL Analysis

5. Global Sublingual Spray Market, by Drug Class
5.1. Global Sublingual Spray Market, Size and Forecast, 2015-2026
5.2. Global Sublingual Spray Market, by Antianginal Agents, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Sublingual Spray Market, by Vasodilators, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Sublingual Spray Market, by Calcium Channel Blocking Agents, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Sublingual Spray Market, by Group IV Antiarrhythmics, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Sublingual Spray Market, by Vitamin And Mineral Combination, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Sublingual Spray Market, by Form
6.1. Global Sublingual Spray Market, Size and Forecast, 2015-2026
6.2. Global Sublingual Spray Market, by Unit Dose Spray, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Sublingual Spray Market, by Bidose Spray, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global Sublingual Spray Market, by Distribution Channel
7.1. Global Sublingual Spray Market, Size and Forecast, 2015-2026
7.2. Global Sublingual Spray Market, by Hospital & Clinics, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Sublingual Spray Market, by Retail & Online Pharmacy, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Sublingual Spray Market, by Other Distribution channel, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global Sublingual Spray Market by Region
8.1. Sublingual Spray Market Regional Analysis, 2015-2026
8.2. Global Sublingual Spray Market Revenue (USD Million) by Region, 2015-2026
8.3. North America Sublingual Spray Market, 2015-2026
8.3.1. North America Sublingual Spray Market Size and Forecast, 2015-2026
8.3.2. North America Sublingual Spray Market by Country, 2015-2026
8.3.2.1. U.S. Sublingual Spray Market, 2015-2026
8.3.2.2. Canada Sublingual Spray Market, 2015-2026
8.4. Europe Sublingual Spray Market, 2015-2026
8.4.1. Europe Sublingual Spray Market Size and Forecast, 2015-2026
8.4.2. Europe Sublingual Spray Market by Country, 2015-2026
8.4.2.1. Germany Sublingual Spray Market, 2015-2026
8.4.2.2. France Sublingual Spray Market, 2015-2026
8.4.2.3. Italy Sublingual Spray Market, 2015-2026
8.4.2.4. UK Sublingual Spray Market, 2015-2026
8.4.2.5. Spain Sublingual Spray Market, 2015-2026
8.4.2.6. Rest of Europe Sublingual Spray Market, 2015-2026
8.5. Asia Pacific Sublingual Spray Market, 2015-2026
8.5.1. Asia Pacific Sublingual Spray Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific Sublingual Spray Market by Country, 2015-2026
8.5.2.1. Japan Sublingual Spray Market, 2015-2026
8.5.2.2. China Sublingual Spray Market, 2015-2026
8.5.2.3. India Sublingual Spray Market, 2015-2026
8.5.2.4. Rest of Asia Pacific Sublingual Spray Market, 2015-2026
8.6. South America Sublingual Spray Market, 2015-2026
8.6.1. South America Sublingual Spray Market Size and Forecast, 2015-2026
8.6.2. South America Sublingual Spray Market by Country, 2015-2026
8.6.2.1. Mexico Sublingual Spray Market, 2015-2026
8.6.2.2. Brazil Sublingual Spray Market, 2015-2026
8.6.2.3. Rest of South America Sublingual Spray Market, 2015-2026
8.7. Middle East & Africa Sublingual Spray Market, 2015-2026
8.7.1. Middle East & Africa Sublingual Spray Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa Sublingual Spray Market by Country, 2015-2026
8.7.2.1. Saudi Arabia Sublingual Spray Market, 2015-2026
8.7.2.2. South Africa Sublingual Spray Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa Sublingual Spray Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. Perrigo Company Plc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Insys Therapeutics, Ltd.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Sun Pharmaceutical Ltd.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Mist Pharmaceuticals
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. NovaDel Pharma Inc.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. Generex Biotechnology Corp.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. GW Pharmaceutical Plc.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Europlaz Technologies
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Piramal Enterprises Ltd.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. Others
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type